Calcitonin for Treating X-linked Hypophosphatemia

Completed · Not applicable · Has a placebo group

Conditions studied: Hypophosphatemic Rickets, X Linked Dominant

In brief

X-linked hypophosphatemia (XLH) is the most common form of inherited rickets in the United States. It also causes bone disease in adults. XLH is caused by overproduction of a hormone call FGF23, which makes the body waste phosphate. This study is designed to determine if nasal calcitonin, an already approved drug in the US, can lower blood levels of FGF23 and reduce phosphate wasting in patients with XLH. In this study the investigators will: 1. Determine whether nasal calcitonin significantly lowers integrated 24-hour blood levels of FGF23 in patients with XLH. 2. Evaluate whether nasal calcitonin improves serum phosphate levels in XLH. 3. Assess whether nasal calcitonin improves blood levels of the active form of vitamin D and calcium absorption from the intestine. 4. Make sure that nasal calcitonin is safe and well tolerated.

Key facts

Study ID

NCT01652573

Run by

Yale University

People needed

21

Starts

2011-03-01

Expected to finish

2015-09-01

Last updated by the study team

2017-05-31

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age ≥18 or greater
• an established diagnosis of XLH
• fasting serum calcium ≤10.5 mg/dl
• fasting PTH at time of screen </= 1.7 times the upper limit of normal

You may not qualify if…

• estimated creatinine clearance < 60 cc/min and/or serum creatinine > 1.5 mg/dl;
• serum 25(OH)vitamin D < 30 ng/ml. Potential study subjects who have a serum 25(OH)vitamin D < 30 ng/ml will be supplemented with 25(OH)vitamin D to achieve a serum value > 30 ng/ml and then re- screened
• inability to comply with instructions and appropriate follow up visits
• treatment with agents that may skeletal metabolism such as glucocorticoids, bisphosphonates, denosumab, teriparatide, estrogen and anticonvulsants.

Where it is running

• Yale School of Medicine — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.